Watch Desk posted an update
Albert Invent has raised $55 million in a Series B round at a reported $340 million valuation. Its AI tools are being used by scientists at Kenvue and Henkel to design experiments, putting the funding behind a concrete industrial chemistry use rather than a lab-only pitch.
Why it mattersWhat happened Forbes reports that Albert Invent launched an AI model trained on chemical patents and data about 15 million molecules. The company’s tools are used by scientists at manufacturing conglomerates Kenvue and Henkel to design experiments. Forbes says the startup raised $55 million in Series B funding at a $340 million valuation. Why it matters Chemistry experiments can be costly and time-consuming. AI tools aimed at helping scientists design them could matter if they help teams choose more useful experiments; the report does not establish how much time or money Albert Invent’s tools save, or what results customers have achieved.
Discuss: Should AI tools for experiment design have to show clear gains over scientists’ existing methods before companies treat them as essential?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.
Your turn
Pull up a chair.
Write first. We’ll sort the introductions when you submit.